Taking University Research into the Marketplace
- 9 September 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 307 (11) , 694-700
- https://doi.org/10.1056/nejm198209093071130
Abstract
Public policy debates about genetic engineering have had three stages. The first, even before the modern molecular work was done, focused on the "chutzpah" of scientists and physicians who were willing to modify human lives and came from colleagues and others with important philosophical and religious reservations.1 , 2 This strain of discussion continues at a low level. The second began with the stunning proposal by leading molecular biologists that a moratorium be placed on their research because of potentially fearsome risks to life or to the environment.3 That stage included the development of guidelines by the National Institutes of Health, the . . .Keywords
This publication has 12 references indexed in Scilit:
- Monsanto Gives Washington U. $23.5 MillionScience, 1982
- The Hoechst Department of Mass GeneralScience, 1982
- Zoecon's quest for success tied to R&DChemical & Engineering News, 1981
- The pharmaceutical industry and academe: Partners in progressThe American Journal of Medicine, 1981
- Profit Sharing between Professors and the University?New England Journal of Medicine, 1981
- Biomedical Research Enters the MarketplaceNew England Journal of Medicine, 1981
- Faculty-Practice PlansNew England Journal of Medicine, 1981
- Research, Innovation, and University-Industry LinkagesScience, 1980
- On the Dangers of Genetic MeddlingScience, 1976
- Brave New World?Science, 1974